New resistance-associated substitutions and failure of dual oral therapy with daclatasvir and asunaprevir.
Mawatari S, Oda K, Tabu K, Ijuin S, Kumagai K, Inada Y, Uto H, Hiramine Y, Kure T, Fujisaki K, Hashiguchi M, Hori T, Oshige A, Imanaka D, Saishoji A, Taniyama O, Sakae H, Tamai T, Moriuchi A, Ido A.
Mawatari S, et al. Among authors: moriuchi a.
J Gastroenterol. 2017 Jul;52(7):855-867. doi: 10.1007/s00535-016-1303-0. Epub 2017 Jan 11.
J Gastroenterol. 2017.
PMID: 28078469